Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 519242 | NSE Symbol : | ISIN : INE995U01011 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
12-May-2025	15-May-2025	Accounts	Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve Intimation of Board Meeting Outcome of Board Meeting held today i.e., 15-05-2025 (As Per BSE Announcement Dated on: 15.05.2025)
08-Apr-2025	08-Apr-2025	Preferential Issue	Outcome of Board Meeting held today i.e, 8th April, 2025
13-Jan-2025	17-Jan-2025	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2025 inter alia to consider and approve Unaudited financial results for the quarter and nine months ended on 31st December 2024. The Board of Directors approved the unaudited financial results for the quarter and nine months ended on 31st December 2024. (As Per BSE Announcement dated on 17.01.2025)
18-Dec-2024	24-Dec-2024	Preferential Issue	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/12/2024 inter alia to consider and approve proposal for fund raising through issue of fresh Equity Shares and / or Convertible Warrants. Outcome of Board Meeting (As Per Bse Announcement Dated on 24.12.2024)
26-Oct-2024	08-Nov-2024	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended on 30th September 2024. The Board of Directors approved the unaudited financial results for the quarter and half year ended on 30th September 2024 in their Board Meeting held today, 8th November 2024. The Board Meeting started at 6.00 pm and was concluded at 7.00 pm on the same day. (As Per BSE Announcement Dated on: 08/11/2024)
26-Oct-2024	26-Oct-2024	Change in Other Executives	Appointment of Company Secretary and Compliance officer.
11-Sep-2024	04-Sep-2024	Change in Directors	The Meeting of the Board of Directors of the Company was held on 4th September 2024 and the outcome of the Meeting was also given on the same date. Revised outcome of the Board meeting is being filed for the Board Meeting held on 4th September 2024 pursuant to SEBI Circular No. SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 with additional details. Please note that the Board of Directors of the Company in their Meeting held today, September 4, 2024 have considered and approved, amongst the other things, the following: 1. Appointment of Mr. Chirag Thumar as Managing Director of the Company. 2. Alteration of Main Object of the Company to start the business in the power sector. 3. Change of Name of the Company. 4. Shifting of Registered office of the Company from the State of Maharashtra to the State of Gujarat. 5. Approved notice of the 33rd Annual General Meeting of the Company. 33rd Annual General Meeting of the Company will be held on Saturday, 28th September 2024 at 4.00 pm through Audio / Visual means. (As Per BSE Announcement Dated on: 04/09/2024)
31-Jul-2024	12-Aug-2024	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter ended on 30th June 2024 to take on record the Limited Review Report on the Un-audited Financial Results for the quarter ended on 30th June 2024 and to consider any other business as per the agenda. The Board of Directors of the Company in their meeting held on Monday, 12th August, 2024 at the Corporate Office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 04:00 P.M. and concluded at 05:45 P.M. , transacted the businesses as attached.
17-Jul-2024	17-Jul-2024	Change in Directors	Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Wednesday, 17th day of July, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 02:00 P.M. and concluded at 03:00 P.M. inter alia transacted businesses as enclosed.
24-Jun-2024	24-Jun-2024	Change in Directors	Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Monday, 24th day of June, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 12:00 P.M. and concluded at 12:30 P.M. inter alia considered and approved the Appointment of Mr. Khilan Hareshbhai Savaliya (DIN: 08790209) as the Additional Director (Non-Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Monday, 24th day of June, 2024.
28-May-2024	28-May-2024	Change in Directors	Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Tuesday, 28th day of May, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 05:00 P.M. and concluded at 06:00 P.M. inter alia considered and approved the appointment of Mr. Chirag Shantilal Thumar (DIN: 10640822) as the Additional Director (Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Tuesday, 28th May, 2024. Read less.. Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Tuesday, 28th day of May, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 05:00 P.M. and concluded at 06:00 P.M. inter alia considered and approved the appointment of Mr. Chirag Shantilal Thumar (DIN: 10640822) as the Additional Director (Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Tuesday, 28th May, 2024. Read less.. (As Per BSE Announcement Dated on 28.05.2024)
20-Apr-2024	30-Apr-2024	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve the Audited Financial Results of the company for the quarter and year ended on 31st March 2024 along with Statement of Assets and Liabilities as on 31st March 2024 and Statement of Cash Flow for the year ended on 31st March 2024 and to take on record the Auditors Report on the Audited Financial Results for the quarter and year ended on 31st March 2024. The Board of Directors of the Company in their meeting held on Tuesday, 30th April, 2024 at the corporate office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 04:00 P.M. and concluded at 06:30 P.M. inter-alia transacted the businesses enclosed herewith. In accordance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024 along with the Statement of Assets and Liabilities as on 31st March, 2024 and Statement of Cash Flow for the year ended on 31st March, 2024 and Auditor''s Report issued with unmodified opinion. Further, a declaration duly signed by the Managing Director and the Chief Financial Officer of the company, pursuant to Regulation 33(3)(d) of the Listing Regulations, read with SEBI Circular CIR/CFD/CMD/56/2016 dated May 27, 2016 to the effect that Auditor''s Report has been issued with unmodified opinion on the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024 is also enclosed herewith. Read less.. (As Per BSE Announcement Dated on 30.04.2024)
05-Feb-2024	13-Feb-2024	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter and nine months ended on 31st December 2023 and to take on record the Limited Review Report on the Un-audited Financial Results for the quarter and nine months ended on 31st December 2023. Approved the Un-audited Financial Results of the Company along with Limited Review Report for the quarter and nine months ended on 31st December, 2023. Approved the Un-audited Financial Results of the company for the quarter and nine months ended on 31st December, 2023 and took on record the Limited Review Report thereon. Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations. (As Per BSE Announcement Dated on 13/02/2024)
01-Dec-2023	30-Nov-2023	Change in Other Executives	Pursuant to Regulation 30(2) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on Thursday, 30th November, 2023 has appointed Mrs. Shipra Gandhi as the Chief Financial Officer (CFO) of the Company with effect from 01st December, 2023.Further, the details of the aforesaid Chief Financial Officer (CFO) required under Regulation 30 read with Part A of Schedule III of the Listing Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 has been attached herewith as Annexure-A.
30-Oct-2023	07-Nov-2023	Quarterly Results	SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter and half year ended on 30th September 2023 along with the Statement of Assets and Liabilities as on 30th September 2023 and Statement of Cash Flow for the half year ended on 30th September 2023; and to take on record the Limited Review Report on the Un-audited Financial Results for the quarter and half year ended on 30th September 2023; Approved the Un-audited Financial Results of the company for the quarter and half year ended on 30th September, 2023 along with the Statement of Assets and Liabilities as on 30th September, 2023 and Statement of Cash Flow for the half year ended on 30th September, 2023 and took on record the Limited Review Report thereon. (Enclosed as Annexure-A) Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations. (As Per BSE Announcement dated on 07.11.2023)

1 2

LOGIN HERE

Sarda Proteins Ltd

Board Meeting